文献速递头颈部肿瘤放疗

头颈癌患者放疗后原发性甲状腺功能减退症:甲状腺剂量体积约束的外部验证及长期内分泌结局

Post-radiation primary hypothyroidism in patients with head and neck cancer: External validation of thyroid gland dose-volume constraints with long-term endocrine outcomes.
PubMed 文献 · Radiother Oncol · 2022-11-03

该外部验证研究评估了22项甲状腺剂量体积约束对头颈癌患者放疗后原发性甲状腺功能减退症的预测价值,纳入两个三级肿瘤中心2013年1月至2015年12月接受颈部照射的488例患者,中位随访6.8年。结果显示甲状腺VS60是预测长期甲状腺功能减退的最佳参数,VS60≥10 cc可将5年风险控制在15%以下。

要点

  • 中位随访6.8年,488例头颈癌患者中205例(42.0%)发生放疗后原发性甲状腺功能减退症。
  • 甲状腺VS60的5年ROC曲线下面积最大为0.698,VS60截断值10 cc的F-score最高为0.53。
  • VS60≥10 cc组5年甲状腺功能减退风险为14.7%,VS60<10 cc组为38.2%(p<0.001)。

核心结论

  • 甲状腺VS60是预测接受颈部照射的头颈癌患者长期原发性甲状腺功能减退风险的最佳剂量体积参数。
  • VS60≥10 cc是稳健的约束条件,可将5年原发性甲状腺功能减退风险限制在15%以下,应在放疗优化中常规采用。

研究设计与样本

  • 外部验证研究,评估文献中提出的22项甲状腺剂量体积约束的诊断性能。
  • 回顾性分析两个三级肿瘤中心2013年1月至2015年12月接受颈部照射的488例头颈癌患者的放疗剂量学数据。
  • 采用逆概率删失加权计算候选约束的诊断指标,并以死亡为竞争事件,使用时间依赖ROC曲线进行比较。
  • 采用Fine-Gray亚分布风险模型进行多变量回归分析。

主要发现

  • 中位随访6.8年期间,205例(42.0%)患者发生放疗后原发性甲状腺功能减退症。
  • 甲状腺VS60在放疗后5年的ROC曲线下面积最大,为0.698。
  • 在所有评估的约束中,VS60截断值10 cc的F-score最高,为0.53。
  • 甲状腺VS60≥10 cc组与<10 cc组的5年甲状腺功能减退风险分别为14.7%和38.2%(p<0.001)。
  • VS60<10 cc的放疗后原发性甲状腺功能减退调整亚分布风险比为1.87(95%CI 1.22-2.87;p<0.001)。

关键数值与推荐

  • VS60<10 cc对应的调整亚分布风险比为1.87(95%CI 1.22-2.87;p<0.001)。
  • VS60≥10 cc组5年甲状腺功能减退风险为14.7%,VS60<10 cc组为38.2%(p<0.001)。
  • VS60在5年时的ROC曲线下面积为0.698,截断值10 cc的F-score为0.53。

临床怎么用

  • 作者认为VS60≥10 cc是稳健的约束条件,可将5年原发性甲状腺功能减退风险限制在15%以下,应在放疗优化中常规采用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Post-radiation primary hypothyroidism is a common late complication in head and neck cancer (HNC) survivors. No radiation dose-volume constraint of the thyroid gland has been externally validated for predicting long-term thyroid function outcomes. MATERIALS AND METHODS: This external validation study evaluated the diagnostic properties of 22 radiation dose-volume constraints of the thyroid gland proposed in the literature. Radiation dosimetric data from 488 HNC patients who underwent neck irradiation from January 2013 to December 2015 at two tertiary oncology centers were reviewed. The diagnostic metrics of candidate constraints were computed by inverse probability of censoring weighting and compared using time-dependent receiver operating characteristic (ROC) curves with death designated as a competing event. Multivariable regression analyses were performed using the Fine-Gray sub-distribution hazard model. RESULTS: Over a median follow-up period of 6.8 years, 205 (42.0 %) patients developed post-radiation primary hypothyroidism. The thyroid volume spared from 60 Gy (VS60) had the largest area under ROC curve of 0.698 at 5 years after radiotherapy. Of all evaluated constraints, VS60 at a cutoff value of 10 cc had the highest F-score of 0.53. The 5-year hypothyroidism risks of patients with thyroid VS60 ≥ 10 cc and < 10 cc were 14.7 % and 38.2 %, respectively (p < 0.001). The adjusted sub-hazard ratio for post-radiation primary hypothyroidism for VS60 < 10 cc was 1.87 (95 % confidence interval, 1.22-2.87; p < 0.001). CONCLUSION: Thyroid VS60 is the best radiation dose-volume parameter to predict the long-term risk of primary hypothyroidism in patients with HNC who underwent neck irradiation. VS60 ≥ 10 cc is a robust constraint that limits the 5-year primary hypothyroidism risk to less than 15 % and should be routinely employed during radiotherapy optimization.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Chow JCH, Lui JCF, Cheung KM, et al. Post-radiation primary hypothyroidism in patients with head and neck cancer: External validation of thyroid gland dose-volume constraints with long-term endocrine outcomes. Radiother Oncol. 2022. PMID: 36336109. doi:10.1016/j.radonc.2022.10.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。